APR 10, 2019 9:00 AM PDT

CRISPR Proteins: Enabling the Next-Generation of Molecular Diagnostics

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Senior Scientist, Mammoth Biosciences
    Biography
      Dr. James Broughton is a Senior Scientist at Mammoth Biosciences. James attended Cornell University for his bachelor's degree in Biology, where he began his career long interest in RNA binding proteins. He then went on to receive his doctorate from UC San Diego. During his graduate work, James applied CRISPR/Cas9 genome editing in the nematode worm C. elegans to investigate the function and specificity of microRNAs. For his postdoc, he joined the lab of Dr. Howard Chang at Stanford University. At Stanford, James examined role of RNA modifications on a newly discovered class of RNA, called circular RNAs. After his postdoc, James brought his expertise in RNA biology and CRISPR systems to Mammoth Biosciences where he works on developing and evaluating new CRISPR-based diagnostic technologies.

    Abstract

    Mammoth Biosciences is developing next-generation CRISPR platforms to build rapid, point-of-care molecular diagnostics. Our innovative DETECTR technology leverages novel CRISPR proteins whose unique biochemical properties make them well-suited for diagnostic applications . By simply altering the nucleotides in their guide RNA (gRNA), CRISPR proteins can be programmed to find and cut any matching DNA or RNA sequence. These unique CRISPR variants additionally interrogate target nucleic acids with single-nucleotide specificity, and they then function themselves as the catalyst for real-time signal detection. The simplicity of CRISPR has already revolutionized the field of gene editing, and is now enabling a new class of diagnostics. Mammoth Biosciences leverages our diverse CRISPR protein portfolio to build a diagnostic platform that is readily scalable to detect any nucleic acid biomarker of interest.

    Learning Objectives:

    1. Develop a general understanding of the diversity of CRISPR-Cas systems
    2. Understand how CRISPR-Cas systems can be used for diagnostic applications


    Show Resources
    You May Also Like
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    JUL 22, 2020 10:00 AM PDT
    C.E. CREDITS
    JUL 22, 2020 10:00 AM PDT
    DATE: July 23, 2020 TIME: 10:00 am PDT The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnost...
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    Loading Comments...
    Show Resources
    Attendees
    • See more